NEWS

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Arndt (CEO), Aneesh (CSO) and John (CTO)

Maxion Therapeutics Raises $72 million (£58 million) in an Oversubscribed Series A Financing to Advance its KnotBody® Pipeline and Platform

A group of five professionals stand together, displaying a trophy, against a backdrop featuring "Maxion Therapeutics" and colorful graphics.

Maxion Therapeutics Highly Commended in ‘Employer of the Year’ Category at Cambridge Independent Science and Technology Awards

Dr Arndt Schottelius

Maxion Therapeutics Welcomes Dr Arndt Schottelius as New CEO

February 1, 2024

Cover of the PwC UK Life Sciences Future50 report, featuring a microscope and text highlighting the report's focus on the life sciences industry.

Maxion Therapeutics’ Breakthrough Science and Innovation Recognised in PwC UK’s Life Sciences Future50 list

October 19, 2023

Eva-Lotta Allan

Ion Channel Drug Developer Maxion Therapeutics Appoints Eva-Lotta Allan as Chair of its Board of Directors

September 21, 2023

Two men stand together, one in a dark suit and light shirt, the other in a plaid shirt and jacket, against a modern, urban backdrop.

Maxion Therapeutics Expands Team and Facilities with Move to Unity Campus

Maxion Therapeutics wins ‘Start-up of the Year’ at 2023 Cambridge Independent Science & Technology Awards

A lab technician in a white coat holds a test tube, surrounded by laboratory equipment and organized storage on the shelves.

Maxion Therapeutics Awarded £2 million Innovate UK Funding To Develop Ion Channel Antibodies For Hard to Treat Autoimmune Diseases

A researcher in a lab coat and purple gloves uses a pipette to transfer liquid into a container, surrounded by lab equipment.

Maxion Therapeutics’ $16 million pre-Series A to drive antibody development for previously untreatable ion channel and GPCR-driven diseases

February 15, 2023

Maxion Therapeutics strengthens its Board with the appointment of Ian Tomlinson (Chairman), Tom Weaver (Non-Executive Director), and Aneesh Karatt Vellatt (Director)

There are no results currently

Contact

Discovering transformational therapies

admin@maxion.co.uk

Follow us on:

Address

The Works, Suite 4 — Unity Campus
London Road
Cambridge, CB22 3FT
United Kingdom